Ligan, Baby Girl B.

HRN: 21-22-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
AMPICILLIN 250MG (VIAL)
04/12/2022
04/19/2022
IV
150MG
Q12
PROM 17H

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Non-compliant To Guidelines